Literature DB >> 27231427

Atherosclerosis and the Hypercholesterolemic AGE-RAGE Axis.

Erick McNair1, Mabood Qureshi1, Kailash Prasad2, Colin Pearce3.   

Abstract

Background Interaction of advanced glycation end products (AGE) with the receptor for advanced glycation end products (RAGE) has been implicated in the pathogenesis of atherosclerosis. Soluble receptors for advanced glycation end products (sRAGE) act as a decoy for AGE by competing with RAGE and suppressing developing atherosclerosis. Hypercholesterolemia and the oxidative stress are known factors involved in atherosclerosis. High-density lipoprotein cholesterol (HDL-C) is known to exert a protective effect against the development of atherosclerosis. We hypothesize that hypercholesterolemia-induced atherosclerosis may be mediated through the AGE-RAGE axis. Objectives Two objectives to be determined are: (1) if hypercholesterolemia is positively correlated with serum AGE, AGE/sRAGE, and malondialdehyde (MDA: a marker for oxidative stress) and (2) if the protective effect of HDL-C is positively associated with serum sRAGE and negatively correlated with the levels of AGE and AGE/sRAGE. Methods Measurement of serum lipid levels from 100 patients allowed the separation into two groups (hypercholesterolemic and normocholesterolemic). Measurements of serum levels of AGE, sRAGE, and MDA were performed. Results Serum levels of sRAGE were lower, while the levels of AGE and AGE/sRAGE were higher in hypercholesterolemic subjects as compared with normocholesterolemic subjects. sRAGE levels are positively correlated with HDL, while they are negatively correlated with low-density lipoprotein, triglycerides, total cholesterol, and MDA in hypercholesterolemic subjects. Conclusions Hypercholesterolemia is positively correlated with serum AGE, AGE/sRAGE, and MDA. The effect of HDL-C may be due to increases in sRAGE and decreases in the levels of AGE and AGE/sRAGE. Hypercholesterolemia-induced atherosclerosis may be mediated through the AGE-RAGE axis; however, more research must be conducted.

Entities:  

Keywords:  advanced glycation end product; atherosclerosis; coronary artery; hypercholesterolemia; oxidative stress

Year:  2016        PMID: 27231427      PMCID: PMC4870054          DOI: 10.1055/s-0035-1570754

Source DB:  PubMed          Journal:  Int J Angiol        ISSN: 1061-1711


  46 in total

1.  Statins stimulate the production of a soluble form of the receptor for advanced glycation end products.

Authors:  Patricia Quade-Lyssy; Anna Maria Kanarek; Markus Baiersdörfer; Rolf Postina; Elzbieta Kojro
Journal:  J Lipid Res       Date:  2013-08-21       Impact factor: 5.922

2.  Low levels of soluble receptor for advanced glycation end products in non-ST elevation myocardial infarction patients.

Authors:  Erick D McNair; Calvin R Wells; A Mabood Qureshi; Rashpal S Basran; Colin Pearce; Jason Orvold; Jacobus Devilliers; Kailash Prasad
Journal:  Int J Angiol       Date:  2009

Review 3.  Clinical aspects of reactive oxygen and nitrogen species.

Authors:  Ascan Warnholtz; Maria Wendt; Michael August; Thomas Münzel
Journal:  Biochem Soc Symp       Date:  2004

4.  Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice.

Authors:  M T Goova; J Li; T Kislinger; W Qu; Y Lu; L G Bucciarelli; S Nowygrod; B M Wolf; X Caliste; S F Yan; D M Stern; A M Schmidt
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

5.  Vitamin E slows the progression of hypercholesterolemia-induced oxidative stress in heart, liver and kidney.

Authors:  Kailash Prasad; Erick D McNair; A Mabood Qureshi; Gudrun Casper-Bell
Journal:  Mol Cell Biochem       Date:  2012-06-20       Impact factor: 3.396

6.  Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE.

Authors:  M P Wautier; O Chappey; S Corda; D M Stern; A M Schmidt; J L Wautier
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-05       Impact factor: 4.310

7.  Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes.

Authors:  A M Schmidt; O Hori; J X Chen; J F Li; J Crandall; J Zhang; R Cao; S D Yan; J Brett; D Stern
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

8.  A disintegrin and metalloproteinase (ADAM)-mediated ectodomain shedding of ADAM10.

Authors:  Edward Parkin; Benjamin Harris
Journal:  J Neurochem       Date:  2009-01-22       Impact factor: 5.372

9.  A study on regression of hypercholesterolemic atherosclerosis in rabbits by flax lignan complex.

Authors:  Kailash Prasad
Journal:  J Cardiovasc Pharmacol Ther       Date:  2007-12       Impact factor: 2.457

10.  Identification, classification, and expression of RAGE gene splice variants.

Authors:  Barry I Hudson; Angela M Carter; Evis Harja; Anastasia Z Kalea; Maria Arriero; Hojin Yang; Peter J Grant; Ann Marie Schmidt
Journal:  FASEB J       Date:  2007-12-18       Impact factor: 5.191

View more
  11 in total

1.  AGEs/sRAGE, a novel risk factor in the pathogenesis of end-stage renal disease.

Authors:  Kailash Prasad; Indu Dhar; Qifeng Zhou; Hamdi Elmoselhi; Muhammad Shoker; Ahmed Shoker
Journal:  Mol Cell Biochem       Date:  2016-10-06       Impact factor: 3.396

2.  Molecular Mechanism of Crataegi Folium and Alisma Rhizoma in the Treatment of Dyslipidemia Based on Network Pharmacology and Molecular Docking.

Authors:  Hui Wang; Hua Wang; Jin Zhang; Jiahui Luo; Caidong Peng; Xiaoyun Tong; Xudong Chen
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-08       Impact factor: 2.650

Review 3.  Current Status of Primary, Secondary, and Tertiary Prevention of Coronary Artery Disease.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2021-08-25

Review 4.  AGE-RAGE Stress and Coronary Artery Disease.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2021-01-21

Review 5.  The use of the soluble receptor for advanced glycation-end products (sRAGE) as a potential biomarker of disease risk and adverse outcomes.

Authors:  Jorge D Erusalimsky
Journal:  Redox Biol       Date:  2021-03-29       Impact factor: 11.799

6.  Analysis of Oxidative Stress-Related Markers in Crohn's Disease Patients at Surgery and Correlations with Clinical Findings.

Authors:  Cristina Luceri; Elisabetta Bigagli; Sara Agostiniani; Francesco Giudici; Daniela Zambonin; Stefano Scaringi; Ferdinando Ficari; Maura Lodovici; Cecilia Malentacchi
Journal:  Antioxidants (Basel)       Date:  2019-09-06

7.  Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD.

Authors:  Katherine A Pratte; Jeffrey L Curtis; Katerina Kechris; David Couper; Michael H Cho; Edwin K Silverman; Dawn L DeMeo; Frank C Sciurba; Yingze Zhang; Victor E Ortega; Wanda K O'Neal; Lucas A Gillenwater; David A Lynch; Eric A Hoffman; John D Newell; Alejandro P Comellas; Peter J Castaldi; Bruce E Miller; Simon D Pouwels; Nick H T Ten Hacken; Rainer Bischoff; Frank Klont; Prescott G Woodruff; Robert Paine; R Graham Barr; John Hoidal; Claire M Doerschuk; Jean-Paul Charbonnier; Ruby Sung; Nicholas Locantore; John G Yonchuk; Sean Jacobson; Ruth Tal-Singer; Debbie Merrill; Russell P Bowler
Journal:  Respir Res       Date:  2021-04-27

8.  Oxidative Stress and Inflammation Are Associated with Coexistent Severe Multivessel Coronary Artery Stenosis and Right Carotid Artery Severe Stenosis in Elderly Patients.

Authors:  Xia Li; Dianxuan Guo; Youdong Hu; Ying Chen
Journal:  Oxid Med Cell Longev       Date:  2021-12-22       Impact factor: 6.543

9.  Increased glycated albumin and decreased esRAGE levels in serum are related to negative coronary artery remodeling in patients with type 2 diabetes: an Intravascular ultrasound study.

Authors:  Run Du; Rui Yan Zhang; Lin Lu; Ying Shen; Li Jin Pu; Zheng Bin Zhu; Qi Zhang; Jian Hu; Zhen Kun Yang; Feng Hua Ding; Jian Sheng Zhang; Wei Feng Shen
Journal:  Cardiovasc Diabetol       Date:  2018-11-27       Impact factor: 9.951

10.  AGEs/RAGE blockade downregulates Endothenin-1 (ET-1), mitigating Human Umbilical Vein Endothelial Cells (HUVEC) injury in deep vein thrombosis (DVT).

Authors:  Yunxin Zhang; Jianlong Liu; Wei Jia; Xuan Tian; Peng Jiang; Zhiyuan Cheng; Jinyong Li
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.